Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Schusser, Benjamin ^a   Yi, Henry ^b   Collarini, Ellen J ^b   Izquierdo, Shelley Mettler ^b   Harriman, William D ^b   Etches, Robert J ^b   Leighton, Philip A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Crystal Bioscience Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES; B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CHICKENS; DNA PRIMERS; FLOW CYTOMETRY; GENE CONVERSION; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84894276781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080108     Document Type: Article

References (39)

1. Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, et al. (2005) The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60: 302-308.
2. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, et al. (1980) Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res 40: 3147-3154.
3. Ritz J, Schlossman SF (1982) Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma. Blood 59: 1-11.
4. Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
5. Hwang WY, Foote J (2005) Immunogenicity of engineered antibodies. Methods 36: 3-10.
6. Steplewski Z, Fox K, Glick J, Koprowski H (1990) Human antimouse antibody response in patients treated with multiple infusions of monoclonal antibody CO17-1A. Front Radiat Ther Oncol 24: 69-72; discussion 121-122.
7. Jones PT, Dear PH, Foote J, Neuberger MS, Winter G (1986) Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321: 522-525.
8. Knight DM, Wagner C, Jordan R, McAleer MF, DeRita R, et al. (1995) The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions. Mol Immunol 32: 1271-1281.
9. Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7: 21-39.
10. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A 81: 6851-6855.
11. Green LL, Hardy MC, Maynard-Currie CE, Tsuda H, Louie DM, et al. (1994) Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs. Nat Genet 7: 13-21.
12. Lonberg N (2005) Human antibodies from transgenic animals. Nat Biotechnol 23: 1117-1125.
13. Lonberg N, Taylor LD, Harding FA, Trounstine M, Higgins KM, et al. (1994) Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368: 856-859.
14. Kuroiwa Y, Kasinathan P, Sathiyaseelan T, Jiao JA, Matsushita H, et al. (2009) Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27: 173-181.
15. Osborn MJ, Ma B, Avis S, Binnie A, Dilley J, et al. (2013) High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igkappa/Iglambda loci bearing the rat CH region. J Immunol 190: 1481-1490.
16. Leighton PA, van de Lavoir MC, Diamond JH, Xia C, Etches RJ (2008) Genetic modification of primordial germ cells by gene trapping, gene targeting, and phiC31 integrase. Mol Reprod Dev 75: 1163-1175.
17. van de Lavoir MC, Diamond JH, Leighton PA, Mather-Love C, Heyer BS, et al. (2006) Germline transmission of genetically modified primordial germ cells. Nature 441: 766-769.
18. Kim S, Humphries EH, Tjoelker L, Carlson L, Thompson CB (1990) Ongoing diversification of the rearranged immunoglobulin light-chain gene in a bursal lymphoma cell line. Mol Cell Biol 10: 3224-3231.
19. Ratcliffe MJ (2006) Antibodies, immunoglobulin genes and the bursa of Fabricius in chicken B cell development. Dev Comp Immunol 30: 101-118.
20. Cumbers SJ, Williams GT, Davies SL, Grenfell RL, Takeda S, et al. (2002) Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines. Nat Biotechnol 20: 1129-1134.
21. Seo H, Masuoka M, Murofushi H, Takeda S, Shibata T, et al. (2005) Rapid generation of specific antibodies by enhanced homologous recombination. Nat Biotechnol 23: 731-735.
22. Yabuki M, Cummings WJ, Leppard JB, Immormino RM, Wood CL, et al. (2012) Antibody discovery ex vivo accelerated by the LacO/LacI regulatory network. PLoS One 7: e36032.
23. Arakawa H, Kudo H, Batrak V, Caldwell RB, Rieger MA, et al. (2008) Protein evolution by hypermutation and selection in the B cell line DT40. Nucleic Acids Res 36: e1.
24. Kanayama N, Todo K, Takahashi S, Magari M, Ohmori H (2006) Genetic manipulation of an exogenous non-immunoglobulin protein by gene conversion machinery in a chicken B cell line. Nucleic Acids Res 34: e10.
25. Blagodatski A, Batrak V, Schmidl S, Schoetz U, Caldwell RB, et al. (2009) A cisacting diversification activator both necessary and sufficient for AID-mediated hypermutation. PLoS Genet 5: e1000332.
26. Kothapalli N, Norton DD, Fugmann SD (2008) Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus. J Immunol 180: 2019-2023.
27. Yang SY, Fugmann SD, Schatz DG (2006) Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J Exp Med 203: 2919-2928.
28. Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, et al. (2012) Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids. J Immunol 188: 322-333.
29. Mohammed SM, Morrison S, Wims L, Trinh KR, Wildeman AG, et al. (1998) Deposition of genetically engineered human antibodies into the egg yolk of hens. Immunotechnology 4: 115-125.
30. Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, Muller W, et al. (1999) IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 27: 209-212.
31. Fu L, Niu B, Zhu Z, Wu S, Li W (2012) CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28: 3150-3152.
32. Li W, Godzik A (2006) Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22: 1658-1659.
33. Birtalan S, Fisher RD, Sidhu SS (2010) The functional capacity of the natural amino acids for molecular recognition. Mol Biosyst 6: 1186-1194.
34. Fellouse FA, Esaki K, Birtalan S, Raptis D, Cancasci VJ, et al. (2007) High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol 373: 924-940.
35. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21: 3926-3934.
36. Reynaud CA, Anquez V, Grimal H, Weill JC (1987) A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell 48: 379-388.
37. Sale JE, Calandrini DM, Takata M, Takeda S, Neuberger MS (2001) Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412: 921-926.
38. Han L, Masani S, Yu K (2011) Overlapping activation-induced cytidine deaminase hotspot motifs in Ig class-switch recombination. Proc Natl Acad Sci U S A 108: 11584-11589.
39. Recillas-Targa F, Pikaart MJ, Burgess-Beusse B, Bell AC, Litt MD, et al. (2002) Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci U S A 99: 6883-6888.